Riten Kumar
Dana-Farber/Boston Children's Cancer and Blood Disorders Center(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management, Platelet Disorders and Treatments, Hemophilia Treatment and Research, Central Venous Catheters and Hemodialysis
Most-Cited Works
- → Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial(2019)299 cited
- → Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C(2021)212 cited
- → Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)(2020)105 cited
- → Ketamine Dependence(2002)86 cited
- → Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism(2022)85 cited
- → Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation(2020)81 cited